SHINIKA CLARK: Open Payments
NPI 1417679176 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 25 payments from 9 companies in 2025. Trend: 2023 $214 · 2024 $475 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $153 |
| Alkermes, Inc. | 5 | $151 |
| Janssen Pharmaceuticals, Inc | 4 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $148 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Almatica Pharma LLC | 1 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Noven Therapeutics, LLC | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
Products named: Auvelity, SPRAVATO, CAPLYTA, ARISTADA, REXULTI, LOREEV XR, INGREZZA, LYBALVI.
Industry payments across FL — which companies pay providers there.
